Biofuel Stock Alert: Solazyme (NASDAQ:SZYM) Closes up over 9%
New York, NY - February 29, 2012 - (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues an investor alert for biofuel stock Solazyme, Inc. (NasdaqGS: SZYM), closing trading for February 28 th at $14.34, up $ 1.21 or (9.22%) on over 1Million shares exchanging hands.
The Company announced last week it will present at a series of cleantech investor conferences from the end of February through to March 7th.
Investorideas.com Newswire
Solazyme, Inc. is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme's renewable products can replace or enhance oils derived from the world's three existing sources - petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care. For more information, please visit our website: http://www.solazyme.com
Research more biofuel stocks on global stock exchanges -and up to 1300 renewable energy stocks at Investorideas.com http://www.investorideas.com/ Companies/ RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more. Join: http://www.investorideas.com/membership/
Disclaimer/ Disclosure : Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp Investorideas.com was not compensated for this report and does not hold a position in the stock
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
contact:
800.665.0411
Investor Ideas, stock and news alerts plus podcasts in bitcoin, blockchain, biotech, cannabis, mining, sports, tech stocks and more
Wednesday, February 29, 2012
Tuesday, February 28, 2012
New Investor Ideas Podast for Renwable energy stocks trading
Header:
Investorideas.com Sector News and Trading Alerts
Please read all Investorideas.com disclaimers and disclosures.
All investment involves risk and possible loss of investment. The audio recording you have listened is not a solicitation to buy and sell securities.
Water Stocks Alert: Cadiz (NASDAQ:CDZI) Trades up on News of Retaining Investment Banking Firm to Lead Water Project Construction Financing
New York, NY - February 28, 2012 - Investorideas.com, a leader in sector research including water stocks issues a news alert for water stock, Cadiz Inc. (NASDAQ:CDZI). The stock is trading up at 10.69 0.25 (2.39%), with a day's high of $10.96.
Investorideas.com Newswire
Cadiz Inc. (NASDAQ:CDZI) announced today that Hannon Armstrong Securities, LLC ("Hannon Armstrong"), an investment bank specializing in the financing of essential infrastructure assets in the United States, including next generation water, energy and telecommunication projects, will lead the Company through the construction financing process for the Cadiz Valley Water Conservation, Recovery and Storage Project (the "Water Project"). The Water Project would provide a new, reliable water supply to Southern California residents by capturing and conserving groundwater currently being lost to evaporation from the aquifer system beneath the Company's 34,000-acre property in California's Mojave Desert.
For over three decades, Hannon Armstrong has been providing and arranging capital for companies and governmental entities seeking innovative, low-cost capital structures for new infrastructure assets. Hannon Armstrong has particular expertise in structuring and placing long term infrastructure project finance, including projects involving multiple governmental agencies. Last year Hannon Armstrong's $400 million Hudson Ranch 1 geothermal power project located in Imperial County, CA received the Project Finance Deal of the Year award from EuroMoney magazine.
The Water Project facilities include an expanded wellfield on the Company's property and a 43-mile underground water conveyance pipeline that would deliver conserved water to the Colorado River Aqueduct, one of Southern California's primary water distribution facilities. Capital costs for construction of the Water Project facilities are estimated at approximately $225 million and Hannon Armstrong expects that these facilities can be privately financed with lower-cost senior debt supporting a lower cost of water.
"Given the Water Project's sound fundamentals and Cadiz's strong asset position, opportunities exist to develop a comprehensive finance solution that will fund the capital requirements on terms customary for public water purveyors," said Jeffrey Eckel, President and CEO of Hannon Armstrong. "The finance solution will be an attractive investment opportunity for long-term investors, such as insurance companies and pension funds, seeking steady fixed-income returns."
Over the last 3 years, the Company has invested more than $15 million in development activities critical to designing a Project that once permitted will avoid environmental harm. The Company has sufficient cash on hand to continue to fund development activities throughout the entitlement phase. The Project is currently undergoing an environmental review pursuant to the California Environmental Quality Act ("CEQA"). A Draft Environmental Impact Report ("EIR") for the Water Project was issued in December 2011 by the Santa Margarita Water District, the Lead Agency for the CEQA review. A public comment period is open until March 14, 2012 and a Final EIR is expected to be issued once all comments have been considered and analyzed.
The Water Project is expected to provide numerous benefits for local communities throughout Southern California, including improvement of local water supply reliability, reduced demand for imported water from Northern California and certain economic improvements. According to a study published by Inland Empire economist Dr. John Husing in May 2011, the Water Project will support over 5,900 jobs, generate more than $878 million in economic activity in the Inland Empire, and infuse millions of dollars in tax revenue to local governments, including $5.4 million per year for San Bernardino County and approximately $613,000 per year for the Needles Unified School District.
About Hannon Armstrong
Hannon Armstrong Securities, LLC is a registered broker dealer and member of FINRA and SIPC that specializes in financing infrastructure assets by arranging capital for companies and governments that are solving the critical infrastructure issues of today. With a head office in Annapolis, MD and a branch office in California, Hannon Armstrong serves a national client base of primarily Fortune 100 companies. Hannon Armstrong has an experienced team of finance professionals committed to creating, funding and managing sound transactions that make a positive contribution to the nation's economic and environmental health. For more information about Hannon Armstrong, visit www.hannonarmstrongsecurities.com.
About Cadiz (NASDAQ:CDZI)
Founded in 1983, Cadiz Inc. is a publicly-held renewable resources company that owns 70 square miles of property with significant water resources and clean energy potential in eastern San Bernardino County, California. The Company is engaged in a combination of water supply and storage, organic farming and solar energy projects, including the Cadiz Valley Water Conservation, Recovery and Storage Project. In 2009 Cadiz adopted a wide-ranging “Green Compact” to implement environmental conservation and sustainable management practices at its properties. For more information about Cadiz, visit www.cadizinc.com.
Linkedin.com: Water Stocks - Social network for investors following water stocks
http://www.linkedin.com/e/ez47wj-gp5ofknw-5j/vgh/3966202/
Linkedin.com Energy Stocks - Social network for investors following energy stocks
http://www.linkedin.com/groups/Energy-stocks-News-Social-Network-3799535?trk=myg_ugrp_ovr
Research water stocks with the water stocks directory:
http://www.investorideas.com/Water-Stocks/Stock_List.asp
Sign up for free investor newsletters and stock alerts at Investor Ideas
http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by news submissions and online advertising. Compensation Disclosure and disclaimers: www.InvestorIdeas.com/About/Disclaimer.asp, http://www.investorideas.com/About/News/Clientspecifics.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For More Information Contact:
Web Site: www.InvestorIdeas.com www.water-stocks.com
800 665 0411
Source: Water-Stocks.com, Investorideas.com
New York, NY - February 28, 2012 - Investorideas.com, a leader in sector research including water stocks issues a news alert for water stock, Cadiz Inc. (NASDAQ:CDZI). The stock is trading up at 10.69 0.25 (2.39%), with a day's high of $10.96.
Investorideas.com Newswire
Cadiz Inc. (NASDAQ:CDZI) announced today that Hannon Armstrong Securities, LLC ("Hannon Armstrong"), an investment bank specializing in the financing of essential infrastructure assets in the United States, including next generation water, energy and telecommunication projects, will lead the Company through the construction financing process for the Cadiz Valley Water Conservation, Recovery and Storage Project (the "Water Project"). The Water Project would provide a new, reliable water supply to Southern California residents by capturing and conserving groundwater currently being lost to evaporation from the aquifer system beneath the Company's 34,000-acre property in California's Mojave Desert.
For over three decades, Hannon Armstrong has been providing and arranging capital for companies and governmental entities seeking innovative, low-cost capital structures for new infrastructure assets. Hannon Armstrong has particular expertise in structuring and placing long term infrastructure project finance, including projects involving multiple governmental agencies. Last year Hannon Armstrong's $400 million Hudson Ranch 1 geothermal power project located in Imperial County, CA received the Project Finance Deal of the Year award from EuroMoney magazine.
The Water Project facilities include an expanded wellfield on the Company's property and a 43-mile underground water conveyance pipeline that would deliver conserved water to the Colorado River Aqueduct, one of Southern California's primary water distribution facilities. Capital costs for construction of the Water Project facilities are estimated at approximately $225 million and Hannon Armstrong expects that these facilities can be privately financed with lower-cost senior debt supporting a lower cost of water.
"Given the Water Project's sound fundamentals and Cadiz's strong asset position, opportunities exist to develop a comprehensive finance solution that will fund the capital requirements on terms customary for public water purveyors," said Jeffrey Eckel, President and CEO of Hannon Armstrong. "The finance solution will be an attractive investment opportunity for long-term investors, such as insurance companies and pension funds, seeking steady fixed-income returns."
Over the last 3 years, the Company has invested more than $15 million in development activities critical to designing a Project that once permitted will avoid environmental harm. The Company has sufficient cash on hand to continue to fund development activities throughout the entitlement phase. The Project is currently undergoing an environmental review pursuant to the California Environmental Quality Act ("CEQA"). A Draft Environmental Impact Report ("EIR") for the Water Project was issued in December 2011 by the Santa Margarita Water District, the Lead Agency for the CEQA review. A public comment period is open until March 14, 2012 and a Final EIR is expected to be issued once all comments have been considered and analyzed.
The Water Project is expected to provide numerous benefits for local communities throughout Southern California, including improvement of local water supply reliability, reduced demand for imported water from Northern California and certain economic improvements. According to a study published by Inland Empire economist Dr. John Husing in May 2011, the Water Project will support over 5,900 jobs, generate more than $878 million in economic activity in the Inland Empire, and infuse millions of dollars in tax revenue to local governments, including $5.4 million per year for San Bernardino County and approximately $613,000 per year for the Needles Unified School District.
About Hannon Armstrong
Hannon Armstrong Securities, LLC is a registered broker dealer and member of FINRA and SIPC that specializes in financing infrastructure assets by arranging capital for companies and governments that are solving the critical infrastructure issues of today. With a head office in Annapolis, MD and a branch office in California, Hannon Armstrong serves a national client base of primarily Fortune 100 companies. Hannon Armstrong has an experienced team of finance professionals committed to creating, funding and managing sound transactions that make a positive contribution to the nation's economic and environmental health. For more information about Hannon Armstrong, visit www.hannonarmstrongsecurities.com.
About Cadiz (NASDAQ:CDZI)
Founded in 1983, Cadiz Inc. is a publicly-held renewable resources company that owns 70 square miles of property with significant water resources and clean energy potential in eastern San Bernardino County, California. The Company is engaged in a combination of water supply and storage, organic farming and solar energy projects, including the Cadiz Valley Water Conservation, Recovery and Storage Project. In 2009 Cadiz adopted a wide-ranging “Green Compact” to implement environmental conservation and sustainable management practices at its properties. For more information about Cadiz, visit www.cadizinc.com.
Linkedin.com: Water Stocks - Social network for investors following water stocks
http://www.linkedin.com/e/ez47wj-gp5ofknw-5j/vgh/3966202/
Linkedin.com Energy Stocks - Social network for investors following energy stocks
http://www.linkedin.com/groups/Energy-stocks-News-Social-Network-3799535?trk=myg_ugrp_ovr
Research water stocks with the water stocks directory:
http://www.investorideas.com/Water-Stocks/Stock_List.asp
Sign up for free investor newsletters and stock alerts at Investor Ideas
http://www.investorideas.com/Resources/Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by news submissions and online advertising. Compensation Disclosure and disclaimers: www.InvestorIdeas.com/About/Disclaimer.asp, http://www.investorideas.com/About/News/Clientspecifics.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For More Information Contact:
Web Site: www.InvestorIdeas.com www.water-stocks.com
800 665 0411
Source: Water-Stocks.com, Investorideas.com
Silver Stock Alert; TSX Junior SilverCrest (TSX.V: SVL) Trades Up over 8%
New York, NY - February 28, 2012 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research for independent investors, issues releases the following trading and news snapshot for silver stock, SilverCrest Mines Inc. ( TSX-V:SVL, OTCQX: STVZF). The stock is trading up at $2.95, up 0.24 (8.86%) 1:07PM EST on over 400,000 shares, with a day's high of $2.97.
The Company announced on February 21st it filed the NI43-101 Technical Report and initial resource estimation for its La Joya Property in Durango, Mexico. Inferred Resources previously announced in a news release dated January 5, 2012 are estimated at 57.9 million tonnes grading 28 gpt silver, 0.18 gpt gold, and 0.21% copper.
Investorideas.com Newswire
SilverCrest Mines Inc. (TSX-V: SVL) is a Mexican precious metals producer with headquarters based in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, which is located 150km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal gold and silver producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag: Au). SilverCrest anticipates that the 2,500 tonnes per day facility should recover approximately 4,805,000 ounces of silver and 179,000 ounces of gold over the 6.5 year life of the open pit phase of the Santa Elena Mine. A three year expansion plan is underway to double metals production at the Santa Elena Mine and exploration programs are rapidly advancing the definition of a large polymetallic deposit at the La Joya property in Durango State.
Research more mining stocks with the Investorideas.com Mining stocks directory
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/ Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/ #!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/ Investorideas
Disclaimer: Investorideas.com does not make stock recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com was not compensated for this release
More info: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
New York, NY - February 28, 2012 - www.InvestorIdeas.com, a global investor research portal, specializing in sector research for independent investors, issues releases the following trading and news snapshot for silver stock, SilverCrest Mines Inc. ( TSX-V:SVL, OTCQX: STVZF). The stock is trading up at $2.95, up 0.24 (8.86%) 1:07PM EST on over 400,000 shares, with a day's high of $2.97.
The Company announced on February 21st it filed the NI43-101 Technical Report and initial resource estimation for its La Joya Property in Durango, Mexico. Inferred Resources previously announced in a news release dated January 5, 2012 are estimated at 57.9 million tonnes grading 28 gpt silver, 0.18 gpt gold, and 0.21% copper.
Investorideas.com Newswire
SilverCrest Mines Inc. (TSX-V: SVL) is a Mexican precious metals producer with headquarters based in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, which is located 150km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal gold and silver producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag: Au). SilverCrest anticipates that the 2,500 tonnes per day facility should recover approximately 4,805,000 ounces of silver and 179,000 ounces of gold over the 6.5 year life of the open pit phase of the Santa Elena Mine. A three year expansion plan is underway to double metals production at the Santa Elena Mine and exploration programs are rapidly advancing the definition of a large polymetallic deposit at the La Joya property in Durango State.
Research more mining stocks with the Investorideas.com Mining stocks directory
Sign up for the free investor news and stock alerts
http://www.investorideas.com/Resources/ Newsletter.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/ #!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/ Investorideas
Disclaimer: Investorideas.com does not make stock recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com was not compensated for this release
More info: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Biopharmaceutical Stock Alimera Sciences (NASDAQ:ALIM) Continues Yesterday's Gains; Up Over 70% on News on ILUVIEN
New York, New York – February 28, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert update for Alimera Sciences, Inc. (NasdaqGM: ALIM), following up on yesterday’s gains, with a monster run in the stock today, moving up another 70% on over 3.6 Million shares in morning trading.
The Company reported today on the positive outcome of the Decentralized Procedure (DCP) for ILUVIEN(R) in Europe. The announcement follows the issuance of the Final Assessment Report from the Reference Member State (RMS), the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA), and the agreement of all the Concerned Member States (CMS) that ILUVIEN is approvable.
ILUVIEN is Alimera's sustained release intravitreal implant that releases sub-microgram levels of fluocinolone acetonide (FAc) for up to 36 months for the treatment of chronic Diabetic Macular Edema.
According to the Company:
ILUVIEN(R) expected to be the first sustained release pharmaceutical in the European Union to treat diabetic macular edema (DME)
ILUVIEN expected to be indicated for chronic DME considered insufficiently responsive to available therapies
Investorideas.com Newswire
Alimera Sciences, Inc., (NASDAQ:ALIM) based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently Alimera is focused on diseases affecting the back of the eye, or retina. Its advanced product candidate, ILUVIEN, is an intravitreal insert containing fluocinolone acetonide (FAc), a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. ILUVIEN is in development for the treatment of DME, a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/ Resources/Newsletter.asp
Research biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/ BIS/Stock_List.asp
Become an Investorideas.com Member
http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
New York, New York – February 28, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert update for Alimera Sciences, Inc. (NasdaqGM: ALIM), following up on yesterday’s gains, with a monster run in the stock today, moving up another 70% on over 3.6 Million shares in morning trading.
The Company reported today on the positive outcome of the Decentralized Procedure (DCP) for ILUVIEN(R) in Europe. The announcement follows the issuance of the Final Assessment Report from the Reference Member State (RMS), the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA), and the agreement of all the Concerned Member States (CMS) that ILUVIEN is approvable.
ILUVIEN is Alimera's sustained release intravitreal implant that releases sub-microgram levels of fluocinolone acetonide (FAc) for up to 36 months for the treatment of chronic Diabetic Macular Edema.
According to the Company:
ILUVIEN(R) expected to be the first sustained release pharmaceutical in the European Union to treat diabetic macular edema (DME)
ILUVIEN expected to be indicated for chronic DME considered insufficiently responsive to available therapies
Investorideas.com Newswire
Alimera Sciences, Inc., (NASDAQ:ALIM) based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently Alimera is focused on diseases affecting the back of the eye, or retina. Its advanced product candidate, ILUVIEN, is an intravitreal insert containing fluocinolone acetonide (FAc), a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. ILUVIEN is in development for the treatment of DME, a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/ Resources/Newsletter.asp
Research biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/ BIS/Stock_List.asp
Become an Investorideas.com Member
http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com
Biodefense Stock News: Vista Partners Updates Coverage on PositiveID Corporation (OTCBB:PSID); $0.38 Target Price
SAN FRANCISCO - February 28, 2012 - (Investorideas.com Newswire) Vista Partners announced today that it has updated coverage on PositiveID Corporation (OTCBB: PSID) ("The Company" or "PSID"); and revised its twelve month target price to $0.38. Ross Silver, Principal Analyst at Vista Partners stated, "The Company's MicroFluidic Systems subsidiary is attempting to secure a portion of the $3.1B Homeland Defense BioWatch pathogen detection contract. The Company is jointly demonstrating its M-BAND device with The Boeing Company and Hamilton Sundstrand at a bioterrorism conference this week." Mr. Silver continues, "We believe the Company's diabetes management products; both FDA approved and under clinical development, could become standards of care. The Company has entered into a partnership with IDEAL LIFE, Inc., a health management leader, to bring iglucose to market. IDEAL LIFE will market iglucose to its large network of customers, including insurance companies, hospitals, and other health care providers. By partnering with IDEAL LIFE, the Company hopes to accelerate market adoption of iglucose. The company anticipates iglucose to be commercially available in the first half of 2012."
To download a FREE copy of the PositiveID Corporation research report, please visit http://www.vistapglobal.com and click the "download research" icon to gain access to the report.
About Vista Partners:
Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista Partners LLC has built a name for itself in the small cap space due to its selection of profitable investment ideas.
Disclaimer & Disclosure:
For a full list of disclaimers and disclosures, please visit our website www.vistapglobal.com.
Contact:
877.215.4813 or info@vistapglobal.com
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/
Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
SAN FRANCISCO - February 28, 2012 - (Investorideas.com Newswire) Vista Partners announced today that it has updated coverage on PositiveID Corporation (OTCBB: PSID) ("The Company" or "PSID"); and revised its twelve month target price to $0.38. Ross Silver, Principal Analyst at Vista Partners stated, "The Company's MicroFluidic Systems subsidiary is attempting to secure a portion of the $3.1B Homeland Defense BioWatch pathogen detection contract. The Company is jointly demonstrating its M-BAND device with The Boeing Company and Hamilton Sundstrand at a bioterrorism conference this week." Mr. Silver continues, "We believe the Company's diabetes management products; both FDA approved and under clinical development, could become standards of care. The Company has entered into a partnership with IDEAL LIFE, Inc., a health management leader, to bring iglucose to market. IDEAL LIFE will market iglucose to its large network of customers, including insurance companies, hospitals, and other health care providers. By partnering with IDEAL LIFE, the Company hopes to accelerate market adoption of iglucose. The company anticipates iglucose to be commercially available in the first half of 2012."
To download a FREE copy of the PositiveID Corporation research report, please visit http://www.vistapglobal.com and click the "download research" icon to gain access to the report.
About Vista Partners:
Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista Partners LLC has built a name for itself in the small cap space due to its selection of profitable investment ideas.
Disclaimer & Disclosure:
For a full list of disclaimers and disclosures, please visit our website www.vistapglobal.com.
Contact:
877.215.4813 or info@vistapglobal.com
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/
Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Monday, February 27, 2012
Biopharmaceutical Stock to Watch; Alimera Sciences (NASDAQ:ALIM) Gains over 35%
New York, New York – February 27, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Alimera Sciences, Inc. (NasdaqGM: ALIM), trading up at $2.3092, gaining 0.5992 or (35.04%) as of 1:22PM EST on over 800,000 shares.
The Company announced Friday that Dan Myers, president and chief executive officer, will present at the Citi 2012 Global Health Care Conference at 1:30 P.M. ET on Wednesday, February 29, 2012 at The Waldorf Astoria Hotel in New York City.
Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently Alimera is focused on diseases affecting the back of the eye, or retina. Its advanced product candidate, ILUVIEN, is an intravitreal insert containing fluocinolone acetonide (FAc), a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. ILUVIEN is in development for the treatment of DME, a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Research biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
Become an Investorideas.com Member
http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
New York, New York – February 27, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Alimera Sciences, Inc. (NasdaqGM: ALIM), trading up at $2.3092, gaining 0.5992 or (35.04%) as of 1:22PM EST on over 800,000 shares.
The Company announced Friday that Dan Myers, president and chief executive officer, will present at the Citi 2012 Global Health Care Conference at 1:30 P.M. ET on Wednesday, February 29, 2012 at The Waldorf Astoria Hotel in New York City.
Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Presently Alimera is focused on diseases affecting the back of the eye, or retina. Its advanced product candidate, ILUVIEN, is an intravitreal insert containing fluocinolone acetonide (FAc), a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. ILUVIEN is in development for the treatment of DME, a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Research biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
Become an Investorideas.com Member
http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
Solar Stocks Weaken - Our Solar Portfolio Continues to Outperform - J Peter Lynch
New York - February 27, 2012 - Solar stocks commentary; Investor Ideas www.Investorideas.com, leader in renewable energy stock research for independent investors, issues a solar stocks update from J. Peter Lynch for Monday February 27th.
Solar Stocks Commentary with J Peter Lynch at Investorideas.com
http://www.investorideas.com/PL/
J. Peter Lynch
Current Status and Past Stop Loss Levels
Our first stop loss point for our 2012 Solar Portfolio was triggered with YGE trading below $4.20. We did not question our system; we simply followed it and sold the position for a small gain of 1.92% on the YGE trade.
Our second action was to sell ½ of the remaining positions on 2/13/2012 when all solar stocks shot up to VERY overbought levels, which I did not think were sustainable.
On Friday (2/24/2012) two more stocks hit their stop points and were sold - GTAT @ $9.00 and TSL @ $8.50.
This leaves the portfolio with two positions - CSIQ (600 shares) and LDK (500 shares). Of the two stocks LDK is the strongest as this time and in fact is the ONLY solar stock that is trading ABOVE both its 50 day moving average (short term positive) and its 200 day moving average (longer term positive).
The current status of the 2012 portfolio is an unrealized gain of 25.74% on the two positions remaining in the portfolio and a realized gain of 20.13% on the positions we have sold.
New Stop Loss Points
As a reminder below are the stop loss points I have selected based upon technical support levels in each stock. I have set these stop points very close, since, as I mentioned in the last article I did expect the markets to pull back due to the fact that they are short term overbought.
The stop loss points for the remaining stocks in our Solar Portfolio are.
CSIQ - $3.50
LDK - $5.25
If either of these stocks reach these levels I would recommend selling that position.
-------------------------------------------------------
Remember - the number one rule of investing:
Minimize your LOSSES and Maximize your GAINS.
--------------------------------------------------------
Market Psychology
The HARDEST THING for investors to do is know when to sell. That is why you have to set specific, non-emotional prices to exit if things do not go right. You cannot allow your emotions to get involved and take over your thinking.
Remember: markets fool the majority of investors by "Climbing a Wall of Worry" which is exactly what it is doing now. Once losses start and keep getting worse when investors get on the "Slopes of Hope" and try and hope that their stock comes back - trust me, the "I hope my stock comes back" technique will NOT work. Trust in your system and follow it regardless of what you think "should happen". Once you try to impose your will on your portfolio you will stop paying attention to what is most important - "what is" NOT what you think it should be.
If you looked at the portfolios of the most successful investors you would, in general, see the following pattern:
Approximately 80% of trades would be either small losses and/or small gains and approximately 20% would be very significant gains. This is exactly how we dramatically outperformed the markets in 2010 and 2011 and continue to outperform since the beginning of 2012. We cut our losses when things did not work out and we let our profitable stock run and maximized our gains.
General Market Comments
At the current time the market is very extended above its 50 day moving average - a level which historically results in a pullback in the market closer to the 50 day moving average. As a result of this I have been setting our stop loss points very conservatively in order to make you that when the correction comes we will still lock in healthy profits.
At this point the general market is STRONGER than the solar stocks as a whole, so when the market pulls back and corrects I would anticipate that our solar stocks will move down further than the market correction.
Keep in mind that periodic corrections are normal in the stock market - what is NOT normal is for the market to be sharply up, without a correction since October 2011.
Background Analysis Notes
Keep in mind that there are two basic types of equity (stock) analysis. Below are a brief description of each and its primary purpose:
Fundamental Analysis - this is the analysis of the fundamental financial condition of a company to identify which stocks you may want to buy when the timing is right. This form of analysis will give you NO indication of the best time to buy a stock or sell a stock.
Technical Analysis - this form of analysis will tell you "when" to buy a stock and when to sell the stock. It will do this by showing you (in chart format) the basic interaction of supply and demand and when the two change and shift which will indicate a time to buy or a time to sell.
Mr. Lynch has worked, for 35 years as a Wall Street security analyst, an independent security analyst and private investor in small emerging technology companies. He has been actively involved in following developments in the renewable energy sector since 1977 and is regarded as an expert in this field. He was the contributing editor for 17 years to the Photovoltaic Insider Report, an early publication in PV that was directed at industrial subscribers, such as major energy companies, utilities and governments around the world. He is currently a private investor and has from time to time been a financial/technology consultant to a number of companies. He can be reached via e-mail at: SOLARJPL@aol.com. Please visit his website for the promotion of solar energy � www.sunseries.net.
Read Solar Stocks Commentary with J Peter Lynch at Investorideas.com
http://www.investorideas.com/PL/
Read Peter's technical solar stock reviews:
http://www.investorideas.com/PL/Solar-Stocks-Review.asp
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com® or any of the industry sector portals. At the time of publication, writers may hold positions in the stocks or companies mentioned.
Research other solar stocks with the renewable energy stocks directory; a global stock directory featuring over 1300 green stocks. Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 12 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit our green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information contact Investor Ideas:
Source: www.Investorideas.com
New York - February 27, 2012 - Solar stocks commentary; Investor Ideas www.Investorideas.com, leader in renewable energy stock research for independent investors, issues a solar stocks update from J. Peter Lynch for Monday February 27th.
Solar Stocks Commentary with J Peter Lynch at Investorideas.com
http://www.investorideas.com/PL/
J. Peter Lynch
Current Status and Past Stop Loss Levels
Our first stop loss point for our 2012 Solar Portfolio was triggered with YGE trading below $4.20. We did not question our system; we simply followed it and sold the position for a small gain of 1.92% on the YGE trade.
Our second action was to sell ½ of the remaining positions on 2/13/2012 when all solar stocks shot up to VERY overbought levels, which I did not think were sustainable.
On Friday (2/24/2012) two more stocks hit their stop points and were sold - GTAT @ $9.00 and TSL @ $8.50.
This leaves the portfolio with two positions - CSIQ (600 shares) and LDK (500 shares). Of the two stocks LDK is the strongest as this time and in fact is the ONLY solar stock that is trading ABOVE both its 50 day moving average (short term positive) and its 200 day moving average (longer term positive).
The current status of the 2012 portfolio is an unrealized gain of 25.74% on the two positions remaining in the portfolio and a realized gain of 20.13% on the positions we have sold.
New Stop Loss Points
As a reminder below are the stop loss points I have selected based upon technical support levels in each stock. I have set these stop points very close, since, as I mentioned in the last article I did expect the markets to pull back due to the fact that they are short term overbought.
The stop loss points for the remaining stocks in our Solar Portfolio are.
CSIQ - $3.50
LDK - $5.25
If either of these stocks reach these levels I would recommend selling that position.
-------------------------------------------------------
Remember - the number one rule of investing:
Minimize your LOSSES and Maximize your GAINS.
--------------------------------------------------------
Market Psychology
The HARDEST THING for investors to do is know when to sell. That is why you have to set specific, non-emotional prices to exit if things do not go right. You cannot allow your emotions to get involved and take over your thinking.
Remember: markets fool the majority of investors by "Climbing a Wall of Worry" which is exactly what it is doing now. Once losses start and keep getting worse when investors get on the "Slopes of Hope" and try and hope that their stock comes back - trust me, the "I hope my stock comes back" technique will NOT work. Trust in your system and follow it regardless of what you think "should happen". Once you try to impose your will on your portfolio you will stop paying attention to what is most important - "what is" NOT what you think it should be.
If you looked at the portfolios of the most successful investors you would, in general, see the following pattern:
Approximately 80% of trades would be either small losses and/or small gains and approximately 20% would be very significant gains. This is exactly how we dramatically outperformed the markets in 2010 and 2011 and continue to outperform since the beginning of 2012. We cut our losses when things did not work out and we let our profitable stock run and maximized our gains.
General Market Comments
At the current time the market is very extended above its 50 day moving average - a level which historically results in a pullback in the market closer to the 50 day moving average. As a result of this I have been setting our stop loss points very conservatively in order to make you that when the correction comes we will still lock in healthy profits.
At this point the general market is STRONGER than the solar stocks as a whole, so when the market pulls back and corrects I would anticipate that our solar stocks will move down further than the market correction.
Keep in mind that periodic corrections are normal in the stock market - what is NOT normal is for the market to be sharply up, without a correction since October 2011.
Background Analysis Notes
Keep in mind that there are two basic types of equity (stock) analysis. Below are a brief description of each and its primary purpose:
Fundamental Analysis - this is the analysis of the fundamental financial condition of a company to identify which stocks you may want to buy when the timing is right. This form of analysis will give you NO indication of the best time to buy a stock or sell a stock.
Technical Analysis - this form of analysis will tell you "when" to buy a stock and when to sell the stock. It will do this by showing you (in chart format) the basic interaction of supply and demand and when the two change and shift which will indicate a time to buy or a time to sell.
Mr. Lynch has worked, for 35 years as a Wall Street security analyst, an independent security analyst and private investor in small emerging technology companies. He has been actively involved in following developments in the renewable energy sector since 1977 and is regarded as an expert in this field. He was the contributing editor for 17 years to the Photovoltaic Insider Report, an early publication in PV that was directed at industrial subscribers, such as major energy companies, utilities and governments around the world. He is currently a private investor and has from time to time been a financial/technology consultant to a number of companies. He can be reached via e-mail at: SOLARJPL@aol.com. Please visit his website for the promotion of solar energy � www.sunseries.net.
Read Solar Stocks Commentary with J Peter Lynch at Investorideas.com
http://www.investorideas.com/PL/
Read Peter's technical solar stock reviews:
http://www.investorideas.com/PL/Solar-Stocks-Review.asp
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com® or any of the industry sector portals. At the time of publication, writers may hold positions in the stocks or companies mentioned.
Research other solar stocks with the renewable energy stocks directory; a global stock directory featuring over 1300 green stocks. Investors also have the option to access the directory as part of the Investor Ideas Membership premium content that currently features an additional 12 stock directories, including the water stocks directory and all cleantech stock directories. http://www.investorideas.com/membership/
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit our green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information contact Investor Ideas:
Source: www.Investorideas.com
Nanotechnology Stocks; mPhase Technologies, Inc. (OTC.BB:XDSL) Accepts Invitation to Visit European Technology Group
LITTLE FALLS, NJ - February 27, 2012 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL.OB) said today that it has accepted an invitation to visit on March 20 and March 21, 2012 a major European Technology "Cluster." The invitation was extended, after the Cluster reviewed mPhase's patent portfolio and the recent valuation and product applications that could result from potential licenses of various patents contained in the portfolio.
mPhase is exploring funding of additional research, development and product commercialization in the areas of reserve batteries using principals of electrowetting and microfluidics. The first day of the visit is to acquaint mPhase with the considerable laboratory resources that could be made available in Europe to continue development and commercialization of its intellectual property. The second day of the visit will introduce mPhase to large commercial firms, including a medical device company, that have indicated interest in establishing partnerships with mPhase for product development.
The focus and interest is based upon the ability of mPhase's Smart Surface technology to electronically control the precise flow of a fluid on a nano-structured surface.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery. In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website:
http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
LITTLE FALLS, NJ - February 27, 2012 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL.OB) said today that it has accepted an invitation to visit on March 20 and March 21, 2012 a major European Technology "Cluster." The invitation was extended, after the Cluster reviewed mPhase's patent portfolio and the recent valuation and product applications that could result from potential licenses of various patents contained in the portfolio.
mPhase is exploring funding of additional research, development and product commercialization in the areas of reserve batteries using principals of electrowetting and microfluidics. The first day of the visit is to acquaint mPhase with the considerable laboratory resources that could be made available in Europe to continue development and commercialization of its intellectual property. The second day of the visit will introduce mPhase to large commercial firms, including a medical device company, that have indicated interest in establishing partnerships with mPhase for product development.
The focus and interest is based upon the ability of mPhase's Smart Surface technology to electronically control the precise flow of a fluid on a nano-structured surface.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery. In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website:
http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Friday, February 24, 2012
Renewable Energy Stock Alert: BioFuel Energy (NASDAQ: BIOF) Up Over 15%
New York, NY - February 24, 2012 - (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues an investor alert for biofuel stock, BioFuel Energy Corp. (NASDAQ: BIOF), trading up at $ 0.7604, up 0.1005(15.23%) on over 6 Million shares.
The Company announced that it will be releasing its fourth quarter and year-end 2011 earnings on Thursday, March 1, 2012, after the market closes.
Investorideas.com Newswire
BioFuel Energy currently has two ethanol plants operating in the Midwestern corn belt. The Company's goal is to become a leading ethanol producer in the United States by acquiring, developing, owning and operating ethanol production facilities.
Research more biofuel stocks on global stock exchanges -and up to 1300 renewable energy stocks at Investorideas.com http://www.investorideas.com/ Companies/ RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Follow Investorideas.com on Twitter http://twitter.com/#!/ nvestorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/ renewableenergystocks
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/ Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more. Join: http://www.investorideas.com/membership/
Disclaimer/ Disclosure : Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp Investorideas.com was not compensated for this report and does not hold a position in the stock
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
Contact: 800.665.0411
New York, NY - February 24, 2012 - (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues an investor alert for biofuel stock, BioFuel Energy Corp. (NASDAQ: BIOF), trading up at $ 0.7604, up 0.1005(15.23%) on over 6 Million shares.
The Company announced that it will be releasing its fourth quarter and year-end 2011 earnings on Thursday, March 1, 2012, after the market closes.
Investorideas.com Newswire
BioFuel Energy currently has two ethanol plants operating in the Midwestern corn belt. The Company's goal is to become a leading ethanol producer in the United States by acquiring, developing, owning and operating ethanol production facilities.
Research more biofuel stocks on global stock exchanges -and up to 1300 renewable energy stocks at Investorideas.com http://www.investorideas.com/ Companies/ RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Follow Investorideas.com on Twitter http://twitter.com/#!/ nvestorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/ renewableenergystocks
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/ Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more. Join: http://www.investorideas.com/membership/
Disclaimer/ Disclosure : Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp Investorideas.com was not compensated for this report and does not hold a position in the stock
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
Contact: 800.665.0411
Biotech Stocks Sector Snapshot and Podcast: VVUS, INFI, SNTS on the Move
New York, NY - February 24, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for notable sector gainers VIVUS, Inc. (NASDAQ: VVUS), Infinity Pharmaceuticals (Nasdaq:INFI) and Santarus, Inc. (NASDAQ:SNTS).
Investorideas.com sector snapshot podcast for biotech stocks, for trading as of Thursday February 23 rd:
Listen to the Investorideas.com Podcast in MP3
VIVUS, Inc. (NASDAQ: VVUS) closed up with massive gains at $18.73, up $8.18(77.54%) with after hours trading moving it to $!8.95, up another 0.22 (1.17%).The day's high on the stock was $21.44 on over 58 Million shares. The stock's monster move was on news that the FDA Advisory Committee had recommended the approval of Qnexa for the treatment of obesity in adults
Infinity Pharmaceuticals (NASDAQ:INFI) closed up at $7.15, up 0.84 or (13.31%). The Company announced on Tuesday that they will be presenting at the Cowen and Company 32nd Annual Health Care Conference on Monday, March 5th
Santarus, Inc. (NASDAQ:SNTS) finished the day at $5.01 up 0.51(11.33%). The Company announced Wednesday that they have entered into a settlement agreement with Lupin to resolve pending patent litigation involving GLUMETZA
About VIVUS
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010. We resubmitted the Qnexa NDA in October 2011, with an FDA action date of April 17, 2012. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, with an FDA action date of April 29, 2012. www.vivus.com.
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
New York, NY - February 24, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for notable sector gainers VIVUS, Inc. (NASDAQ: VVUS), Infinity Pharmaceuticals (Nasdaq:INFI) and Santarus, Inc. (NASDAQ:SNTS).
Investorideas.com sector snapshot podcast for biotech stocks, for trading as of Thursday February 23 rd:
Listen to the Investorideas.com Podcast in MP3
VIVUS, Inc. (NASDAQ: VVUS) closed up with massive gains at $18.73, up $8.18(77.54%) with after hours trading moving it to $!8.95, up another 0.22 (1.17%).The day's high on the stock was $21.44 on over 58 Million shares. The stock's monster move was on news that the FDA Advisory Committee had recommended the approval of Qnexa for the treatment of obesity in adults
Infinity Pharmaceuticals (NASDAQ:INFI) closed up at $7.15, up 0.84 or (13.31%). The Company announced on Tuesday that they will be presenting at the Cowen and Company 32nd Annual Health Care Conference on Monday, March 5th
Santarus, Inc. (NASDAQ:SNTS) finished the day at $5.01 up 0.51(11.33%). The Company announced Wednesday that they have entered into a settlement agreement with Lupin to resolve pending patent litigation involving GLUMETZA
About VIVUS
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010. We resubmitted the Qnexa NDA in October 2011, with an FDA action date of April 17, 2012. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, with an FDA action date of April 29, 2012. www.vivus.com.
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
Biodefense Stocks to Watch in 2012; PositiveID (OTCBB:PSID) and Northrop Grumman (NYSE: NOC) Opportunities with BioWatch
New York, NY - February 24, 2012 - (Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an investor snapshot of Homeland Security and Biodefense stocks , PositiveIDCorporation (OTCBB: PSID) and Northrop Grumman (NYSE: NOC), two potentially qualified biodetector systems suppliers for BioWatch Gen-3.
The Department of Homeland Security Office of Procurement Operations anticipates soliciting final Phase II RFP for the first or second quarter of FY 2012.The Gen-3 detection system will be a fully autonomous network of biodetectors that will continuously monitor the air for biothreat agents.
In a recent interview with Investorideas.com. Mr. William J. Caragol, Chairman and Chief Executive Officer of PositiveIDCorporation (OTCBB: PSID) noted, "Our MicroFluidic Systems ("MFS") subsidiary, is a leader in biothreat detection technologies and molecular diagnostic systems, and developed its M-BAND technology under contract from DHS over the past eight years. We believe our M-BAND, a Microfluidics-based Bioagent Autonomous Networked Detector, is one of only two technologies that is compatible with DHS' procurement for Gen-3 of Biowatch, which has a total value of more than $3 billion over approximately five years, as described by the DHS in their draft RFP. This opportunity, relative to the provision of biodetectors and the renewables, represents a very significant opportunity for PositiveID. "
PositiveID Corporation (OTCBB: PSID) announced it will present its M-BAND (Microfluidics-based Bioagent Autonomous Networked Detector) system at the 10th Annual American Society for Microbiology ("ASM") Biodefense and Emerging Diseases Research Meeting, to be held February 26-29, 2012, in Washington, DC at the Omni Shoreham Hotel. PositiveID will jointly exhibit M-BAND with The Boeing Company and Hamilton Sundstrand.
Northrop Grumman's (NYSE: NOC) biodefense division will be a key player in Biowatch as it moves forward, with previous contracts announced back in 2010. Northrop delivered critical assay technology to DHS as part of the company's BioWatch Gen-3 contract .The assay represents the key technological component of Northrop Grumman's BioWatch Gen-3 system.
According to the company's press release, Northrop Grumman's Advanced Concepts & Technologies Division is providing its Next-Gen Automated Detection Systems (NG-ADS) for independent laboratory and field testing at military and national laboratories.
"Automating the bio-detection process in these next generation instruments will provide much earlier warning of a bio-terrorism attack," said Dave Tilles, vice president of homeland defense programs at Northrop Grumman. "It will operate 24 hours per day, 365 days per year, in select cities across the nation. Earlier warning will allow the nation's public health and safety officials to reduce exposure, distribute medication sooner and proactively manage the response to a bio-threat."
As the RFP for Biowatch moves forward in 2012, investors can follow the money flow from DHS as qualified biodetector systems are contracted and deployed.
More info on Biowatch; follow the updates:
https://www.fbo.gov/index?s=opportunity&mode=form&id=2372ab5f30917fdbacca73f3fa5f0e9c&tab=core&_cview=1
Learn more about PSID at Investorideas.com
http://www.investorideas.com/CO/PSID/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation ( OTCBB:PSID ) featured biotech company on Investorideas.com for 3 months effective January 30, 2012. Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact Investorideas.com 800 665 0411
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/
New York, NY - February 24, 2012 - (Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an investor snapshot of Homeland Security and Biodefense stocks , PositiveIDCorporation (OTCBB: PSID) and Northrop Grumman (NYSE: NOC), two potentially qualified biodetector systems suppliers for BioWatch Gen-3.
The Department of Homeland Security Office of Procurement Operations anticipates soliciting final Phase II RFP for the first or second quarter of FY 2012.The Gen-3 detection system will be a fully autonomous network of biodetectors that will continuously monitor the air for biothreat agents.
In a recent interview with Investorideas.com. Mr. William J. Caragol, Chairman and Chief Executive Officer of PositiveIDCorporation (OTCBB: PSID) noted, "Our MicroFluidic Systems ("MFS") subsidiary, is a leader in biothreat detection technologies and molecular diagnostic systems, and developed its M-BAND technology under contract from DHS over the past eight years. We believe our M-BAND, a Microfluidics-based Bioagent Autonomous Networked Detector, is one of only two technologies that is compatible with DHS' procurement for Gen-3 of Biowatch, which has a total value of more than $3 billion over approximately five years, as described by the DHS in their draft RFP. This opportunity, relative to the provision of biodetectors and the renewables, represents a very significant opportunity for PositiveID. "
PositiveID Corporation (OTCBB: PSID) announced it will present its M-BAND (Microfluidics-based Bioagent Autonomous Networked Detector) system at the 10th Annual American Society for Microbiology ("ASM") Biodefense and Emerging Diseases Research Meeting, to be held February 26-29, 2012, in Washington, DC at the Omni Shoreham Hotel. PositiveID will jointly exhibit M-BAND with The Boeing Company and Hamilton Sundstrand.
Northrop Grumman's (NYSE: NOC) biodefense division will be a key player in Biowatch as it moves forward, with previous contracts announced back in 2010. Northrop delivered critical assay technology to DHS as part of the company's BioWatch Gen-3 contract .The assay represents the key technological component of Northrop Grumman's BioWatch Gen-3 system.
According to the company's press release, Northrop Grumman's Advanced Concepts & Technologies Division is providing its Next-Gen Automated Detection Systems (NG-ADS) for independent laboratory and field testing at military and national laboratories.
"Automating the bio-detection process in these next generation instruments will provide much earlier warning of a bio-terrorism attack," said Dave Tilles, vice president of homeland defense programs at Northrop Grumman. "It will operate 24 hours per day, 365 days per year, in select cities across the nation. Earlier warning will allow the nation's public health and safety officials to reduce exposure, distribute medication sooner and proactively manage the response to a bio-threat."
As the RFP for Biowatch moves forward in 2012, investors can follow the money flow from DHS as qualified biodetector systems are contracted and deployed.
More info on Biowatch; follow the updates:
https://www.fbo.gov/index?s=opportunity&mode=form&id=2372ab5f30917fdbacca73f3fa5f0e9c&tab=core&_cview=1
Learn more about PSID at Investorideas.com
http://www.investorideas.com/CO/PSID/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation ( OTCBB:PSID ) featured biotech company on Investorideas.com for 3 months effective January 30, 2012. Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Contact Investorideas.com 800 665 0411
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/
Thursday, February 23, 2012
Water stocks sector snapshot pocast for February 23
Investorideas.com Sector News and Trading Alerts
Please read all Investorideas.com disclaimers and disclosures.
All investment involves risk and possible loss of investment. The audio recording you have listened is not a solicitation to buy and sell securities.
Biopharmaceutical Stock to Watch: VIVUS (NASDAQ: VVUS) Massive Move on FDA Approval of Qnexa®
New York, NY - February 23, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for biopharmaceutical stock VIVUS, Inc. (NASDAQ: VVUS). The stock is trading up at$18.92 8.37(79.34%) with a day high of $21.44 on volume of over 51 Million shares.
VIVUS, Inc. (NASDAQ: VVUS) reported yesterday that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee recommended Qnexa be granted marketing approval by the FDA for the treatment of obesity in adults. The Committee voted 20 to 2, on the recommendation for an approval based on a favorable benefit-risk profile.
About VIVUS
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010. We resubmitted the Qnexa NDA in October 2011, with an FDA action date of April 17, 2012. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, with an FDA action date of April 29, 2012. www.vivus.com.
Get biotech news and stock alerts
http://www.investorideas.com/ Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/ BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
New York, NY - February 23, 2012 - Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for biopharmaceutical stock VIVUS, Inc. (NASDAQ: VVUS). The stock is trading up at$18.92 8.37(79.34%) with a day high of $21.44 on volume of over 51 Million shares.
VIVUS, Inc. (NASDAQ: VVUS) reported yesterday that the U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee recommended Qnexa be granted marketing approval by the FDA for the treatment of obesity in adults. The Committee voted 20 to 2, on the recommendation for an approval based on a favorable benefit-risk profile.
About VIVUS
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010. We resubmitted the Qnexa NDA in October 2011, with an FDA action date of April 17, 2012. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, with an FDA action date of April 29, 2012. www.vivus.com.
Get biotech news and stock alerts
http://www.investorideas.com/ Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/ BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
Mining Stocks; YALE (TSX-V: YLL) Expands Gold Mineralized Zones at San Pedro, Urique
VANCOUVER, British Columbia - February 23, 2012 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL, OTCBB: YRLLF, and Frankfurt: YAB) is pleased to report that a comprehensive work program is now underway at the Urique Project, located in Chihuahua State, Mexico, immediately north of Goldcorp's El Sauzal gold mine and immediately south of Kimber Resources' Monterde Property. Work at Urique is being performed on behalf of optionee Mammoth Resources Ltd. (MTH � TSX.V).
The initial results from sampling at the San Pedro Target has identified multiple new zones of gold mineralization and confirmed the strong potential of previously known zones. Gold and silver mineralization at San Pedro is interpreted to be low to intermediate sulfidation and occurs as widely spaced quartz vein/stockwork zones and shear zones associated with felsic dykes hosted in strongly altered volcanic rocks.
Important gold values (greater than 0.3 g/t Au) now have been identified throughout an area measuring approximately 1,400 metres by 1,000 metres. In this initial phase, 121 rock chip samples were taken from quartz veins/stockwork zones and their immediate wall rock near or at the entrance of small mine workings. Highlights from this first widespread sampling are listed below:
To date only a combined 50.6 linear meters of trenches have been sampled. A number of trenches are open and need to be extended to fully define the following results (see table above for detail):
The Company currently has four geologists dedicated to the project based out of two camps that are used as the bases of operations to cover the northern portion of the property � Urique North and the southern portion of the property � Urique South.
Work in Urique North will be concentration on the San Pedro target before moving on to the Cuiteco Target and other anomalies whereas the field program in Urique South Ongoing work will continue to develop a geological database and understanding of the Urique Target Area, which contains greater than 20 historic producing mines, as well as investigate numerous other targets and prospects located in the southern portion of the property that borders Goldcorp's El Sauzal property. The goal of this work is to advance the primary target areas to the drill-ready stage as rapidly as possible.
About Yale Resources:
Yale Resources utilizes the project generator business model to maximize its exposure to discovery while minimizing shareholder risk. Yale currently has nine projects in its portfolio of which five are optioned out with commitments totalling approximately $1.3 M in expenditures during the next 12 months. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects.
Ian Foreman, P.Geo, is Yale's Qualified Person, according to National Instrument 43-101, for the Dos Naciones properties and is responsible for any technical data mentioned in this news release.
Samples from Dos Naciones were prepared and analyzed by IPL Inspectorate in their facilities in Mexico and Vancouver, respectively. Samples generally consisted of 1-3 kg of material. Gold analyses were performed by 30 gram fire assay with an AA finish. Silver, copper, lead and zinc were analyzed as part of a multi-element ICP package using an aqua regia digestion. Over limit samples with greater than 1% Cu, Pb and Zn were re-analyzed using ore grade detection limits.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President
For additional information on Yale Resources please call the Company at 604-678-2531.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
Contact:
Yale Resources Ltd.
Ian Foreman
604-678-2531
VANCOUVER, British Columbia - February 23, 2012 (Investorideas.com Mining stocks Newswire) - Yale Resources Ltd. (TSX-V: YLL, OTCBB: YRLLF, and Frankfurt: YAB) is pleased to report that a comprehensive work program is now underway at the Urique Project, located in Chihuahua State, Mexico, immediately north of Goldcorp's El Sauzal gold mine and immediately south of Kimber Resources' Monterde Property. Work at Urique is being performed on behalf of optionee Mammoth Resources Ltd. (MTH � TSX.V).
The initial results from sampling at the San Pedro Target has identified multiple new zones of gold mineralization and confirmed the strong potential of previously known zones. Gold and silver mineralization at San Pedro is interpreted to be low to intermediate sulfidation and occurs as widely spaced quartz vein/stockwork zones and shear zones associated with felsic dykes hosted in strongly altered volcanic rocks.
Important gold values (greater than 0.3 g/t Au) now have been identified throughout an area measuring approximately 1,400 metres by 1,000 metres. In this initial phase, 121 rock chip samples were taken from quartz veins/stockwork zones and their immediate wall rock near or at the entrance of small mine workings. Highlights from this first widespread sampling are listed below:
To date only a combined 50.6 linear meters of trenches have been sampled. A number of trenches are open and need to be extended to fully define the following results (see table above for detail):
- Trench 2 - first sample returned 1.55 g/t gold
- Trench 4 - first sample returned 3.77 g/t gold
- Trench 6 - first sample returned 18.78 g/t gold and the last sample returned 1.63 g/t gold
- Trench 7 - first sample returned 0.53 g/t gold and the last sample returned 4.07 g/t gold
The Company currently has four geologists dedicated to the project based out of two camps that are used as the bases of operations to cover the northern portion of the property � Urique North and the southern portion of the property � Urique South.
Work in Urique North will be concentration on the San Pedro target before moving on to the Cuiteco Target and other anomalies whereas the field program in Urique South Ongoing work will continue to develop a geological database and understanding of the Urique Target Area, which contains greater than 20 historic producing mines, as well as investigate numerous other targets and prospects located in the southern portion of the property that borders Goldcorp's El Sauzal property. The goal of this work is to advance the primary target areas to the drill-ready stage as rapidly as possible.
About Yale Resources:
Yale Resources utilizes the project generator business model to maximize its exposure to discovery while minimizing shareholder risk. Yale currently has nine projects in its portfolio of which five are optioned out with commitments totalling approximately $1.3 M in expenditures during the next 12 months. At the same time Yale continues to work on its non-optioned properties as well as reviewing new projects.
Ian Foreman, P.Geo, is Yale's Qualified Person, according to National Instrument 43-101, for the Dos Naciones properties and is responsible for any technical data mentioned in this news release.
Samples from Dos Naciones were prepared and analyzed by IPL Inspectorate in their facilities in Mexico and Vancouver, respectively. Samples generally consisted of 1-3 kg of material. Gold analyses were performed by 30 gram fire assay with an AA finish. Silver, copper, lead and zinc were analyzed as part of a multi-element ICP package using an aqua regia digestion. Over limit samples with greater than 1% Cu, Pb and Zn were re-analyzed using ore grade detection limits.
On behalf of the Board,
"Ian Foreman"
Ian Foreman, P.Geo.
President
For additional information on Yale Resources please call the Company at 604-678-2531.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Statements in this press release, other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, may include forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in resource exploration and development. As a result, actual results may vary materially from those described in the forward-looking statements.
Contact:
Yale Resources Ltd.
Ian Foreman
604-678-2531
Visit the YLL showcase profile at Investorideas.com
Request News and Info on YLL
Disclosure, Disclaimer/ Investorideas.com is paid by YLL to publish news and distribute content through Investordeas.com Newswire and its syndicated partners and blogs (five hundred per month)
Request News and Info on YLL
Disclosure, Disclaimer/ Investorideas.com is paid by YLL to publish news and distribute content through Investordeas.com Newswire and its syndicated partners and blogs (five hundred per month)
Wednesday's Renewable Energy Stock Leaders: WEST, MY, PLUG, QTWW
New York, NY - February 23, 2012 - (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues a sector close-up for trading for February 22 nd . Notable gainers included China Ming Yang Wind Power (NYSE: MY), Plug Power. (NasdaqCM: PLUG), Quantum Fuel Systems. (NasdaqGM: QTWW) and W estinghouse Solar (NasdaqCM: WEST).
Wind stock, China Ming Yang Wind Power (NYSE: MY) ended the day at $2.73, up 0.23(9.20%) followed by gains of 0.04 (1.60%) in after hours trading.
Plug Power, Inc. (NasdaqCM: PLUG) finished up at $2.55, gaining 0.22(9.44%), with after hours trading moving the stock up to $2.61, up another 0.06 (2.35%). The Company today announced it will release the Company's 2011 fourth quarter and year end results on March 8, 2012.
Quantum Fuel Systems Technologies Worldwide, Inc. (NasdaqGM: QTWW) had double digit gains closing up at $1.09, up 0.14(14.72%), with an after hours move to $1.14, up another 0.05 (4.59%). The Company reported yesterday on the closing bell that it received a letter from Nasdaq Staff notifying the Company that because the closing bid price of the Company's common stock was at least $1.00 per share for at least 10 consecutive business days it has regained compliance with The Nasdaq Stock Market's $1.00 minimum bid price rule set forth in Listing Rule 5450(a) (1) and the matter is now closed.
Solar stock, Westinghouse Solar, Inc. (NasdaqCM: WEST) closed trading at $0.67, gaining 0.06(9.84%) on over 87, 000 shares. Last week the Company announced it has signed a letter of intent to pursue a business combination with CBD Energy (ASX: CBD.AX), a renewable energy company based in Sydney, Australia. Terms of the transaction have been approved by the boards of directors of both companies, subject to satisfactory completion of due diligence and definitive agreements. The companies are targeting execution of definitive documents in early March and a third quarter closing date, subject to shareholder approvals and other customary closing conditions.
Research more solar stocks on global stock exchanges -and up to 1300 renewable energy stocks at Investorideas.com http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more. Join: http://www.investorideas.com/membership/
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
contact:
800.665.0411
New York, NY - February 23, 2012 - (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research for independent investors, issues a sector close-up for trading for February 22 nd . Notable gainers included China Ming Yang Wind Power (NYSE: MY), Plug Power. (NasdaqCM: PLUG), Quantum Fuel Systems. (NasdaqGM: QTWW) and W estinghouse Solar (NasdaqCM: WEST).
Wind stock, China Ming Yang Wind Power (NYSE: MY) ended the day at $2.73, up 0.23(9.20%) followed by gains of 0.04 (1.60%) in after hours trading.
Plug Power, Inc. (NasdaqCM: PLUG) finished up at $2.55, gaining 0.22(9.44%), with after hours trading moving the stock up to $2.61, up another 0.06 (2.35%). The Company today announced it will release the Company's 2011 fourth quarter and year end results on March 8, 2012.
Quantum Fuel Systems Technologies Worldwide, Inc. (NasdaqGM: QTWW) had double digit gains closing up at $1.09, up 0.14(14.72%), with an after hours move to $1.14, up another 0.05 (4.59%). The Company reported yesterday on the closing bell that it received a letter from Nasdaq Staff notifying the Company that because the closing bid price of the Company's common stock was at least $1.00 per share for at least 10 consecutive business days it has regained compliance with The Nasdaq Stock Market's $1.00 minimum bid price rule set forth in Listing Rule 5450(a) (1) and the matter is now closed.
Solar stock, Westinghouse Solar, Inc. (NasdaqCM: WEST) closed trading at $0.67, gaining 0.06(9.84%) on over 87, 000 shares. Last week the Company announced it has signed a letter of intent to pursue a business combination with CBD Energy (ASX: CBD.AX), a renewable energy company based in Sydney, Australia. Terms of the transaction have been approved by the boards of directors of both companies, subject to satisfactory completion of due diligence and definitive agreements. The companies are targeting execution of definitive documents in early March and a third quarter closing date, subject to shareholder approvals and other customary closing conditions.
Research more solar stocks on global stock exchanges -and up to 1300 renewable energy stocks at Investorideas.com http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com on Google Plus
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 24/7 Login to 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks, tech and more. Join: http://www.investorideas.com/membership/
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com
contact:
800.665.0411
Wednesday, February 22, 2012
Renewable Energy Stock Trading Alert: Clean Wind Energy Tower, Inc. (OTCBB:CWET) Pays Off Convertible Note
ANNAPOLIS, Md. - February 22, 2012 (Investorideas.com renewable energy/green newswire) Clean Wind Energy Tower, Inc. (OTCBB:CWET) (the "Company") announced today that the Asher Enterprises, LLC, note, convertible into common stock, entered into on August 23, 2011, in the amount of $32,500 was paid off in cash. No shares of the Company's common stock from this note are being held in reserve for conversion.
Ronald W. Pickett, Chairman and CEO, stated, "The Company is pleased to report the timely repayment of this incremental financing".
About Clean Wind Energy, Inc.
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc., has designed and is preparing to develop and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies.
Our Company's core objective and focus is to become a provider of clean efficient green energy to the world communities at a reasonable cost without the destructive residuals of fossil fuel, and to help broker the chasm between both, while continuing to generate innovative technological solutions for today and tomorrow's electrical power needs.
Abundant, Clean, Affordable Energy
As designed, the Company anticipates that each Downdraft Tower could generate enough electricity to power up to 1,600,000 homes using the guidelines set forth in the California Statewide Residential Appliance Saturation Study, 2004. As an independent power producer of clean, renewable energy, the Company will not be selling power directly to consumers but rather to the grid. As currently designed, the Company anticipates that each Downdraft Tower will be capable of generating 1,100 megawatts per hour of salable electricity to the grid. One megawatt equates to 1,000,000 watts or 1,000 kilowatts of electricity. Currently, avoided costs per kilowatt in California are running approximately $0.11 per kilowatt hour.
In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology. Clean Wind Energy, Inc. is based in Annapolis MD, and is traded on the OTCBB under the symbol 'CWET'.
Company Contact:
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
Investor Relations Contact:
Jody Janson
Phone: (855) 848-6937
Email: ir@cwetower.com
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
ANNAPOLIS, Md. - February 22, 2012 (Investorideas.com renewable energy/green newswire) Clean Wind Energy Tower, Inc. (OTCBB:CWET) (the "Company") announced today that the Asher Enterprises, LLC, note, convertible into common stock, entered into on August 23, 2011, in the amount of $32,500 was paid off in cash. No shares of the Company's common stock from this note are being held in reserve for conversion.
Ronald W. Pickett, Chairman and CEO, stated, "The Company is pleased to report the timely repayment of this incremental financing".
About Clean Wind Energy, Inc.
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc., has designed and is preparing to develop and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies.
Our Company's core objective and focus is to become a provider of clean efficient green energy to the world communities at a reasonable cost without the destructive residuals of fossil fuel, and to help broker the chasm between both, while continuing to generate innovative technological solutions for today and tomorrow's electrical power needs.
Abundant, Clean, Affordable Energy
As designed, the Company anticipates that each Downdraft Tower could generate enough electricity to power up to 1,600,000 homes using the guidelines set forth in the California Statewide Residential Appliance Saturation Study, 2004. As an independent power producer of clean, renewable energy, the Company will not be selling power directly to consumers but rather to the grid. As currently designed, the Company anticipates that each Downdraft Tower will be capable of generating 1,100 megawatts per hour of salable electricity to the grid. One megawatt equates to 1,000,000 watts or 1,000 kilowatts of electricity. Currently, avoided costs per kilowatt in California are running approximately $0.11 per kilowatt hour.
In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology. Clean Wind Energy, Inc. is based in Annapolis MD, and is traded on the OTCBB under the symbol 'CWET'.
Company Contact:
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
Investor Relations Contact:
Jody Janson
Phone: (855) 848-6937
Email: ir@cwetower.com
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Visit the CWET showcase page at Investorideas.com:
http://www.investorideas.com/CO/CWE/
http://www.investorideas.com/CO/CWE/
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com and our Green Investor content:http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on wind stocks
http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asphttp://www.investorideas.com/Resources/Newsletter.asp
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com
Nanotechnology Stocks; mPhase Technologies, Inc. (OTC.BB:XDSL) Files Drug Delivery Patent
LITTLE FALLS, NJ - February 22, 2012 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL.OB) said today that it has filed a provisional patent application for a novel drug delivery system based on its Smart Surface technology.
The drug delivery patent is based on the ability of mPhase's Smart Surface technology to electronically control the precise flow of a fluid on a nano-structured surface.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery. In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website:
http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
LITTLE FALLS, NJ - February 22, 2012 (Investorideas.com Newswire) - mPhase Technologies, Inc. (OTC.BB: XDSL.OB) said today that it has filed a provisional patent application for a novel drug delivery system based on its Smart Surface technology.
The drug delivery patent is based on the ability of mPhase's Smart Surface technology to electronically control the precise flow of a fluid on a nano-structured surface.
About mPhase Technologies, Inc.
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and microfluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery. In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website:
http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
Forward-Looking Statements
As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company's SEC filings, including the financial statements and related information contained in the Company's SEC Filing. mPhase assumes no obligation to update the information in this release.
Contact:
973-256-3737
mPhase Technologies, Inc.
Visit the XDSL showcase profile at Investorideas.com
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Request News and Info on XDSL
Disclosure, Disclaimer/ XDSL is a paid advertising client on Investorideas.com and our technology portals.
Tuesday, February 21, 2012
UK Call to become a Leader in Wave and Tidal Power Moves Ocean Power Technologies (NASDAQ:OPTT) Stock Up
New York, New York - February 21, 2012 - (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading alert for wave technology stock Ocean Power Technologies, Inc. (Nasdaq:OPTT).
The stock is currently trading at 3.5708 0.3908(12.29%) with a high of $3.90 following a report from the UK entitled, Energy and Climate Change - Eleventh Report -The Future of Marine Renewables in the UK . The report, published by the House of Commons pushes for the UK to become a global leader in marine renewables.
According to the UK Parliament site, "The UK could become a leading exporter of wave and tidal power equipment and expertise if the Government adopts a more visionary approach to developing marine renewables, according to a new report by the Energy and Climate Change Select Committee."
Ocean Power Technologies, Inc. (NASDAQ:OPTT)
Ocean Power Technologies, Inc. is a pioneer in wave-energy technology that harnesses ocean wave resources to generate reliable and clean and environmentally-beneficial electricity. OPT has a strong track record in the advancement of wave energy and participates in an estimated $150 billion annual power generation equipment market. OPT’s proprietary PowerBuoy® system is based on modular, ocean-going buoys that capture and convert predictable wave energy into clean electricity. The Company is widely recognized as a leading developer of on-grid and autonomous wave-energy generation systems, benefiting from 15 years of in-ocean experience. OPT is headquartered in Pennington, New Jersey, USA with an office in Warwick, UK. More information can be found at www.oceanpowertechnologies.com.
News link on UK report: Here
Research over 1300 other green stocks on global stock exchanges with Investor Ideas stock directory
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Join Investor Ideas - Become a Member
Get login access to 13 stock directories including the Renewable Energy stocks directory, water stocks directory, plus hot news and stock alerts, directories updated each month
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by OPTT
For more information about Investorideas.com contact:
800.665.0411
New York, New York - February 21, 2012 - (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading alert for wave technology stock Ocean Power Technologies, Inc. (Nasdaq:OPTT).
The stock is currently trading at 3.5708 0.3908(12.29%) with a high of $3.90 following a report from the UK entitled, Energy and Climate Change - Eleventh Report -The Future of Marine Renewables in the UK . The report, published by the House of Commons pushes for the UK to become a global leader in marine renewables.
According to the UK Parliament site, "The UK could become a leading exporter of wave and tidal power equipment and expertise if the Government adopts a more visionary approach to developing marine renewables, according to a new report by the Energy and Climate Change Select Committee."
Ocean Power Technologies, Inc. (NASDAQ:OPTT)
Ocean Power Technologies, Inc. is a pioneer in wave-energy technology that harnesses ocean wave resources to generate reliable and clean and environmentally-beneficial electricity. OPT has a strong track record in the advancement of wave energy and participates in an estimated $150 billion annual power generation equipment market. OPT’s proprietary PowerBuoy® system is based on modular, ocean-going buoys that capture and convert predictable wave energy into clean electricity. The Company is widely recognized as a leading developer of on-grid and autonomous wave-energy generation systems, benefiting from 15 years of in-ocean experience. OPT is headquartered in Pennington, New Jersey, USA with an office in Warwick, UK. More information can be found at www.oceanpowertechnologies.com.
News link on UK report: Here
Research over 1300 other green stocks on global stock exchanges with Investor Ideas stock directory
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Join Investor Ideas - Become a Member
Get login access to 13 stock directories including the Renewable Energy stocks directory, water stocks directory, plus hot news and stock alerts, directories updated each month
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by OPTT
For more information about Investorideas.com contact:
800.665.0411
Biodefense Stock News: PositiveID (OTCBB:PSID) to Present M-BAND at ASM Biodefense and Emerging Diseases Research Meeting February 26-29
DELRAY BEACH, Fla., February 21, 2012 - (Investorideas.com Newswire) PositiveID Corporation's (OTCBB: PSID) subsidiary MicroFluidic Systems (“MFS”), a developer of molecular diagnostic systems, announced today it will present its M-BAND (Microfluidics-based Bioagent Autonomous Networked Detector) system at the 10 th Annual American Society for Microbiology (“ASM”) Biodefense and Emerging Diseases Research Meeting, to be held February 26-29, 2012, in Washington, DC at the Omni Shoreham Hotel. PositiveID will jointly exhibit M-BAND with The Boeing Company (NYSE:BA) and Hamilton Sundstrand.
M-BAND, developed under contract for the Department of Homeland Security by MFS, is an early warning system designed to detect the intentional release of aerosolized biological agents . It runs autonomously for up to 30 days, continuously analyzing air samples, typically in high-traffic areas, for the detection of bacteria, viruses, and toxins with results in as little as three hours. Results from individual M-BAND instruments are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instruments in aggregate. Designed with a high level of operational flexibility, M-BAND can be remotely set to detect for DNA-based pathogens alone, with or without either RNA-based organisms or toxins, or for all three types of pathogens simultaneously at remotely programmable intervals.
According to the ASM, approximately 1,000 leaders and decision makers in the field of biodefense will participate in the Biodefense and Emerging Diseases conference to discuss the critical research necessary to defend against the growing threat of bioterrorism and shape the future of the biodefense research agenda.
About PositiveID Corporation
PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including the likelihood that PositiveID will present its M-BAND system at the ASM Biodefense and Emerging Diseases Research Meeting; the likelihood that PositiveID will jointly exhibit M-BAND with The Boeing Company and Hamilton Sundstrand; the likelihood that approximately 1,000 leaders and decision makers in the field of biodefense will participate in the Biodefense and Emerging Diseases conference to discuss the critical research necessary to defend against the growing threat of bioterrorism and shape the future of the biodefense research agenda; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully commercialize M-BAND; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Contact:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Published at the Investorideas.com Newswire and syndicated blogs
Learn more about PSID at Investorideas.com
http://www.investorideas.com/CO/PSID/
Disclaimer /Disclosure : Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
DELRAY BEACH, Fla., February 21, 2012 - (Investorideas.com Newswire) PositiveID Corporation's (OTCBB: PSID) subsidiary MicroFluidic Systems (“MFS”), a developer of molecular diagnostic systems, announced today it will present its M-BAND (Microfluidics-based Bioagent Autonomous Networked Detector) system at the 10 th Annual American Society for Microbiology (“ASM”) Biodefense and Emerging Diseases Research Meeting, to be held February 26-29, 2012, in Washington, DC at the Omni Shoreham Hotel. PositiveID will jointly exhibit M-BAND with The Boeing Company (NYSE:BA) and Hamilton Sundstrand.
M-BAND, developed under contract for the Department of Homeland Security by MFS, is an early warning system designed to detect the intentional release of aerosolized biological agents . It runs autonomously for up to 30 days, continuously analyzing air samples, typically in high-traffic areas, for the detection of bacteria, viruses, and toxins with results in as little as three hours. Results from individual M-BAND instruments are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instruments in aggregate. Designed with a high level of operational flexibility, M-BAND can be remotely set to detect for DNA-based pathogens alone, with or without either RNA-based organisms or toxins, or for all three types of pathogens simultaneously at remotely programmable intervals.
According to the ASM, approximately 1,000 leaders and decision makers in the field of biodefense will participate in the Biodefense and Emerging Diseases conference to discuss the critical research necessary to defend against the growing threat of bioterrorism and shape the future of the biodefense research agenda.
About PositiveID Corporation
PositiveID Corporation develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. For more information on PositiveID, please visit www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including the likelihood that PositiveID will present its M-BAND system at the ASM Biodefense and Emerging Diseases Research Meeting; the likelihood that PositiveID will jointly exhibit M-BAND with The Boeing Company and Hamilton Sundstrand; the likelihood that approximately 1,000 leaders and decision makers in the field of biodefense will participate in the Biodefense and Emerging Diseases conference to discuss the critical research necessary to defend against the growing threat of bioterrorism and shape the future of the biodefense research agenda; and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include PositiveID's ability to successfully commercialize M-BAND; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 25, 2011, and 10-Qs filed on May 13, 2011, August 15, 2011, and November 14, 2011, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Contact:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Published at the Investorideas.com Newswire and syndicated blogs
Learn more about PSID at Investorideas.com
http://www.investorideas.com/CO/PSID/
Disclaimer /Disclosure : Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. PositiveID Corporation (OTCBB:PSID) featured biotech company on Investorideas.com for 3 months effective January 30,2012 . Compensation: two hundred fifty thousand 144 shares for news release publication, syndication on blogs and related sites and email distribution and company profile . More info: www.InvestorIdeas.com/About/Disclaimer.asp and disclosures: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
PositiveID Corporation (OTCBB:PSID) is a featured biotech company on Investorideas.com
Visit the company profile: http://www.investorideas.com/CO/PSID/
Visit the company profile: http://www.investorideas.com/CO/PSID/
Subscribe to:
Posts (Atom)